RxDoctor Payments Data

Jordan Houston, PA

Medical · Savannah, GANPI 1013446103

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (46.7%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. AbbVie accounts for 62.8% of it on its own, with 28 other manufacturers making up the rest. 2025 is the largest year on record at $4,799, 6.3 times the $767 reported in 2021. Among medical clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$11,558in general payments, 2019–2025

Across 257 payments — averaging $44.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$7K
  • Nestle Healthcare Nutrition Inc.$867
  • Medtronic$534
  • Gilead$373
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$313
  • Johnson & Johnson$226
  • plus $2K from 23 others

What the payments were for

  • Speaking & faculty fees$5,40047%
  • Travel & lodging$7627%
  • Food & beverage$5,38247%
  • Education$140%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,558 in reported general payments places this provider in the 95th percentile of 950 medical providers in Georgia.

See all medical providers in Georgia

Medicare billing

Part B allowed, 2024
$75,245
Medicare patients
573
Services billed
717

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LinzessLinaclotide112$91,468
CreonLipase/Protease/Amylase15$68,139
Mesalamine19$15,494
TrulancePlecanatide12$10,166
Lubiprostone24$3,729
Ondansetron Hcl73$2,506
Colesevelam Hcl22$2,212
Omeprazole147$1,922
Pantoprazole Sodium138$1,655
Esomeprazole Magnesium25$1,366
Famotidine75$944
Dicyclomine Hcl83$636
Sucralfate11$554
CholestyramineCholestyramine (With Sugar)13$503
Lansoprazole13$381

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess, Creon$7,260$159,607127 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance$313$10,16612 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 950 medical providers in Georgia.

Other medical in Savannah

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →